Swiftalyn Wart Remover

Manufacturer
Shenzhen Peruidaishi Technology Co., Ltd.
Effective date
2024-01-25
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:12:28

Label at a glance#

ProductSwiftalyn Wart Remover
Active ingredientACETIC ACID, BENZOIC ACID
Label structure12 sections

Dosage and administration

1. cleanse and dry the affected area. 2 Use the brush or cotton swab to apply the wart remaval liquid onthe wart Gently dab onto the affected area. if the wart is large, usetapping motins to cover the entire affected area. 3. Donot rub. 4. Allow 3-5 minutes for the skin to absorb it fully. 5.Apply twice a day, in the morning and evening

Storage and handling

Keep it away from children. Seal the bottle and place it in a cool and dry place.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzoic Acid 25%
Acetic Acid 25%

Purpose

OTC - PURPOSE SECTION

Remove Warts & Re pair Skin

Use

INDICATIONS & USAGE SECTION

Remove Warts & Re pair Skin

Warnings

WARNINGS SECTION

Do not use it on your face..External use only. Pregnant and breastfeeding women should be usedwith caution
* Avoid getting the product into your eyes. if it accidentally getsinto theeyes, rinse it off with water immediately..stop using and ask a physician if irritation occurs.Stop use if there is no improvement within d weeks.. keep it away from children.. it is normal for the treated wart to appear red and swollen if thishappens, stop using the product for 3-5 days Once the rednesssubsides, continue to use the product until the wart completely folls off.

Do not use

OTC - DO NOT USE SECTION

Ahays perform a skin patch test before using the product. lf iritation occurs discontinue use.

When Using

OTC - WHEN USING SECTION

it is normal for the treated wart to appear red and swollen. if thishappens, stop using the product for3-5 days Once the rednesssubsides, continue to use the product until the wart completely falls off.
You should begin to see the effects within 3-5 days.Typically, most minor warts take around 10 days to beremoved, while larger warts may require a longerduration for complete removal and healing

Stop Use

OTC - STOP USE SECTION

Stop use if there is no improvement within 4 weeks.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep it away from children. Seal the bottle and place it in a cool and dry place.

Directions

DOSAGE & ADMINISTRATION SECTION

1. cleanse and dry the affected area.

2 Use the brush or cotton swab to apply the wart remaval liquid onthe wart Gently dab onto the affected area. if the wart is large, usetapping motins to cover the entire affected area.

3. Donot rub.

4. Allow 3-5 minutes for the skin to absorb it fully.

5.Apply twice a day, in the morning and evening

Other information

STORAGE AND HANDLING SECTION

Keep it away from children. Seal the bottle and place it in a cool and dry place.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water
Alcohol Denat
Propylene Glycol
Angelica Dahurica Root
Asiatic Acid

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84048-00384048-003-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
126e27c0-ea60-51bc-e063-6394a90a81e10fc0970d-06a4-ade9-e063-6394a90ae7ff2024-02-28WarningsExact identifier
spl set id: 0fc0970d-06a4-ade9-e063-6394a90ae7ff

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.